Starbucks (SBUX) earnings Q2 2024

A store of Starbucks Coffee shop chain located in Amsterdam city center with people sitting inside, enjoying a coffee after shopping in the cafe, while others are walking by. Nicolas Economou | Nurphoto | Getty ImagesStarbucks is expected to report its fiscal second-quarter earnings after the bell on Tuesday.Here's what...

Read more...

FTC challenges patents held by drugmakers, including for Ozempic

A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31, 2023. Lee Smith | ReutersThe Federal Trade Commission on Tuesday said it is challenging hundreds of alleged "junk" patents held by pharmaceutical companies for 20 brand-name drugs, including Novo Nordisk's blockbuster drugs Ozempic,...

Read more...

Walmart to shutter health centers, virtual care service

Walmart on Tuesday said it will close all of its health-care clinics across the country, a stunning reversal of its plans to bring its low-priced reputation to the dentist and doctor's office along with the grocery aisle. The big-box retailer said it would also shutter its telehealth provider, which it...

Read more...

Coca-Cola (KO) Q1 2024 earnings

A Coca-Cola building in Zagreb, Croatia, Nov. 8, 2023.Denis Lovrovic | AFP | Getty ImagesCoca-Cola on Tuesday reported quarterly earnings and revenue that beat analysts' expectations.The beverage giant also raised its full-year outlook for organic revenue.Shares of the company rose less than 1% in premarket trading.Here's what the company...

Read more...

McDonald’s (MCD) Q1 2024 earnings

McDonald's french friesPicture Alliance | Picture Alliance | Getty ImagesMcDonald's is expected to report its first-quarter earnings before the bell on Tuesday.Here's what Wall Street analysts surveyed by LSEG are expecting:Earnings per share: $2.72 expectedRevenue: $6.16 billion expectedThe fast-food giant reported disappointing fourth-quarter sales. Boycotts after its Israeli licensee...

Read more...

J&J, Bristol Myers Squibb lose Medicare drug-price talks challenges

Jonathan Raa | Nurphoto | Getty ImagesA federal judge in New Jersey on Monday rejected Johnson & Johnson's and Bristol Myers Squibb's legal challenges to the Biden administration's Medicare drug-price negotiations, ruling that the program is constitutional. The decision is another win for the White House in a bitter legal...

Read more...